19.11.2020 Views

South African Psychiatry - November 2020

South African Psychiatry - November 2020

South African Psychiatry - November 2020

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

OROS ® engineered

for full patient benefits 1 Effective 1 Affordable 2

* * * *

14146

*Not actual size

References: 1. Coghill D, Seth S. Osmotic, controlled-release methylphenidate for the treatment of ADHD. Expert Opinion Pharmacotherapy 2006;7(15):2119-2138. 2. Data on File.

S6 NEUCON ® OROS ® 18 mg, 27 mg, 36 mg or 54 mg extended-release tablets containing 18 mg, 27 mg, 36 mg, 54 mg of methylphenidate hydrochloride, respectively. Reg. No’s.: 46/1.2/0380; 46/1.2/0381;46/1.2/0382; 46/1.2/0383.

For full prescribing information, refer to the package insert April 2018.

LICENCE HOLDER: Janssen Pharmaceutica, Reg. No.: 1980/011122/07, No. 2, Medical Street, Halfway House, Midrand, 1685. Tel: (011) 518 7000. www.janssen.co.za

Marketed by sanofi-aventis south africa (pty) ltd, reg. no.: 1996/010381/07. 2 Bond Street, Grand Central Ext. 1, Midrand, 1685, South Africa. Tel: (011) 256 3700.

Fax: (011) 256 3707. www.sanofi.com. CP-97720

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!